Loading clinical trials...
Loading clinical trials...
This study aims to exploratorily evaluate the extent of motor and cognitive changes, as well as the safety, resulting from approximately 10 weeks of whole-body photobiomodulation (PBM) therapy (about ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pusan National University Yangsan Hospital
NCT07478146 · PARKINSON DISEASE (Disorder)
NCT07467460 · PARKINSON DISEASE (Disorder), Alzheimer s Disease, and more
NCT07422675 · PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease
NCT07217054 · PARKINSON DISEASE (Disorder), Parkinson, and more
NCT07360977 · PARKINSON DISEASE (Disorder), Multiple Sclerosis (MS) - Relapsing-remitting, and more
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions